Cargando…
KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer
Most prostate cancer (PCa) cases remain indolent with a relatively good prognosis. However, bone metastasis of PCa can quickly worsen prognoses and lead to mortality. Metastasis-free survival (MFS), a strong surrogate for overall survival, is widely used in PCa prognosis research. The present study...
Autores principales: | Wang, Haoyuan, Li, Sijie, Liu, Bin, Wei, Shufei, Wang, Tianyi, Li, Tao, Lin, Jiahu, Ni, Xiaochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353809/ https://www.ncbi.nlm.nih.gov/pubmed/35949593 http://dx.doi.org/10.3892/ol.2022.13432 |
Ejemplares similares
-
KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification
por: Wang, Haoyuan, et al.
Publicado: (2023) -
Prognostic value of circWWC3 as a novel survival‑related biomarker for clear cell renal cell carcinoma
por: Wang, Haoyuan, et al.
Publicado: (2023) -
KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
por: Zhou, Yan, et al.
Publicado: (2023) -
Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2021) -
Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer
por: Daigo, Kayo, et al.
Publicado: (2017)